Unknown

Dataset Information

Analysis of reported adverse events of pipeline stents for intracranial aneurysms using the FDA MAUDE database.


ABSTRACT:

Objective

Flow diverting stents (FDS) are a validated device in the treatment of intracranial aneurysms, allowing for minimally invasive intervention. However, after its approval for use in the United States in 2011, post-market surveillance of adverse events is limited. This study aims to address this critical knowledge gap by analyzing the FDA Manufacturer and User Facility Device Experience (MAUDE) database for patient and device related (PR and DR) reports of adverse events and malfunctions.

Methods

Using post-market surveillance data from the MAUDE database, PR and DR reports from January 2012-December 2021 were extracted, compiled, and analyzed with R-Studio version 2021.09.2. PR and DR reports with insufficient information were excluded. Raw information was organized,

SUBMITTER: Porwal MH 

PROVIDER: S-EPMC10555618 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature